Diabetes on the Net is intended for healthcare professionals
The Boehringer Ingelheim and Lilly Diabetes Alliance has provided the funding for this promotional meeting, including speaker honoraria and presentation support where applicable
Click here for prescribing Information and adverse event reporting (UK) JARDIANCE (empagliflozin)
Click here for prescribing information and adverse event reporting (IE) JARDIANCE (empagliflozin)
This promotional video presentation was originally broadcast on 6 November 2020. Please note that the speakers are not able to answer questions from attendees watching the video on-demand.
get the latest news
subscribe now
© Copyright OmniaMed Communications. All Rights Reserved
We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.